scholarly article | Q13442814 |
P50 | author | Mariza de Andrade | Q42067404 |
Julie M. Cunningham | Q67440680 | ||
P2093 | author name string | Ping Yang | |
Yan Li | |||
Zhifu Sun | |||
Claude Deschamps | |||
Jason A Wampfler | |||
Stephen J Swensen | |||
Ruoxiang Jiang | |||
Paul D Scanlon | |||
Andrew H Limper | |||
David E Midthun | |||
Randolph S Marks | |||
Curtis L Olswold | |||
P2860 | cites work | Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century | Q22305613 |
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 | ||
Lung cancer susceptibility locus at 5p15.33 | Q24649980 | ||
Inflammation and cancer: back to Virchow? | Q28036756 | ||
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers | Q28259916 | ||
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. | Q28290169 | ||
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study | Q28383607 | ||
The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks | Q28592473 | ||
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research | Q28754732 | ||
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 | Q28943480 | ||
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 | Q29614944 | ||
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 | ||
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. | Q33419815 | ||
A rigorous and comprehensive validation: common genetic variations and lung cancer | Q33586584 | ||
Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
A chronic obstructive pulmonary disease related signature in squamous cell lung cancer | Q33690263 | ||
Characterization of the omega class of glutathione transferases. | Q33992754 | ||
RRM1-induced metastasis suppression through PTEN-regulated pathways | Q34189695 | ||
Gene and pathway-based second-wave analysis of genome-wide association studies | Q34328480 | ||
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history | Q34604212 | ||
Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction | Q34768018 | ||
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease | Q35855187 | ||
Microsatellite DNA instability in benign lung diseases. | Q36187814 | ||
Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review | Q36444282 | ||
State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer | Q36571997 | ||
Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population | Q36609353 | ||
Systemic inflammation in COPD: is genetic susceptibility a key factor? | Q36686862 | ||
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk | Q36926072 | ||
Combining p-values in large-scale genomics experiments. | Q36942509 | ||
A report of cytokine polymorphisms and COPD risk in Xuan Wei, China | Q37091594 | ||
Genetic influences in common respiratory disorders | Q37142910 | ||
Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival | Q37591139 | ||
Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. | Q37834029 | ||
The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer | Q37839576 | ||
Analysis of multiple SNPs in a candidate gene or region | Q38939126 | ||
Alternative RNA splicing in expression of the glutathione synthetase gene in human cells | Q39813630 | ||
Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells | Q40046116 | ||
Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins | Q42651323 | ||
CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD. | Q43192187 | ||
Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. | Q43955722 | ||
Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. | Q45975173 | ||
Lung cancer gene associated with COPD: triple whammy or possible confounding effect? | Q46269161 | ||
Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease | Q46423277 | ||
Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes | Q46638108 | ||
How accurate is the self-reported diagnosis of chronic bronchitis? | Q51701196 | ||
hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease. | Q54479503 | ||
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine | Q57693007 | ||
Localization of γ-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease | Q58317020 | ||
Induction of γ-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells | Q58317043 | ||
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society | Q68060128 | ||
Alpha 1-antitrypsin Pi-types in 965 COPD patients | Q68793944 | ||
Genetic Epidemiology of COPD | Q77763667 | ||
Chromosome 4q31 locus in COPD is also associated with lung cancer | Q82674649 | ||
A Panel of Sputum-Based Genomic Marker for Early Detection of Lung Cancer | Q85073752 | ||
P433 | issue | 3 | |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
P304 | page(s) | 365-373 | |
P577 | publication date | 2011-11-01 | |
P1433 | published in | Cancer Prevention Research | Q2665103 |
P1476 | title | Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer | |
P478 | volume | 5 |
Q41056681 | Association of GCLM -588C/T and GCLC -129T/C Promoter Polymorphisms of Genes Coding the Subunits of Glutamate Cysteine Ligase with Ischemic Heart Disease Development in Kazakhstan Population |
Q36320998 | Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease |
Q38315516 | DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences |
Q33732176 | Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients |
Q34993176 | Evaluation of DNA damage in COPD patients and its correlation with polymorphisms in repair genes. |
Q46423514 | Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration. |
Q51700279 | Genetic regulation of gene expression in the lung identifies CST3 and CD22 as potential causal genes for airflow obstruction. |
Q37536837 | Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease |
Q35375709 | Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients |
Q39530290 | Relationship between gene polymorphisms of two cytokine genes (TNF-α and IL-6) and occurring of lung cancers in the ethnic group Han of China |
Q33558881 | Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease |
Search more.